CLINICAL TRIALS

On-going Studies

A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Patients With Clinically Evident Cardiovascular Disease

The primary clinical hypothesis is that long-term exposure of evolocumab will be safe and well tolerated in subjects with clinically evident atherosclerotic cardiovascular disease (CVD)

​​​​​

Neurocare, Center for Sleep

70 Wells Avenue, Newton MA 02459
ph. 617-796-7766
fax 617-796-9099

© 2018 Neurocare, Inc.  All rights reserved.

  • Facebook - Black Circle